NO162821C - Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater.Info
- Publication number
- NO162821C NO162821C NO853782A NO853782A NO162821C NO 162821 C NO162821 C NO 162821C NO 853782 A NO853782 A NO 853782A NO 853782 A NO853782 A NO 853782A NO 162821 C NO162821 C NO 162821C
- Authority
- NO
- Norway
- Prior art keywords
- furo
- procedure
- preparation
- group
- pyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Mushroom Cultivation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8414842A FR2570701B1 (fr) | 1984-09-27 | 1984-09-27 | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO853782L NO853782L (no) | 1986-04-01 |
| NO162821B NO162821B (no) | 1989-11-13 |
| NO162821C true NO162821C (no) | 1990-02-21 |
Family
ID=9308136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO853782A NO162821C (no) | 1984-09-27 | 1985-09-26 | Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4661498A (da) |
| EP (1) | EP0178201B1 (da) |
| JP (1) | JPS61106577A (da) |
| KR (1) | KR860002508A (da) |
| AT (1) | ATE40554T1 (da) |
| AU (1) | AU573390B2 (da) |
| CA (1) | CA1291994C (da) |
| DE (1) | DE3568045D1 (da) |
| DK (1) | DK158953C (da) |
| ES (1) | ES8605522A1 (da) |
| FI (1) | FI82054C (da) |
| FR (1) | FR2570701B1 (da) |
| GR (1) | GR852356B (da) |
| HU (1) | HU192365B (da) |
| IL (1) | IL76535A0 (da) |
| NO (1) | NO162821C (da) |
| NZ (1) | NZ213620A (da) |
| PT (1) | PT81206B (da) |
| ZA (1) | ZA857457B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2566775B1 (fr) * | 1984-06-27 | 1986-10-31 | Synthelabo | Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique |
| FR2619112B1 (fr) * | 1987-08-07 | 1989-11-17 | Synthelabo | Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique |
| FR2635977B1 (fr) * | 1988-09-07 | 1992-05-15 | Synthelabo | Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite |
| US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
| US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
| UA70334C2 (en) | 1998-10-06 | 2004-10-15 | Janssen Pharmaceutica N V Jans | BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS |
| SK285560B6 (sk) | 1998-12-21 | 2007-03-01 | Janssen Pharmaceutica N. V. | Benzisoxazoly a fenoly ako alfa2-antagonisty, spôsob ich prípravy a farmaceutický prostriedok |
| AU776276B2 (en) * | 1999-01-19 | 2004-09-02 | Neurosearch A/S | Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (da) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
| DD210278A5 (de) * | 1982-03-05 | 1984-06-06 | Boehringer Ingelheim Kg | Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine |
-
1984
- 1984-09-27 FR FR8414842A patent/FR2570701B1/fr not_active Expired
-
1985
- 1985-09-06 EP EP85401732A patent/EP0178201B1/fr not_active Expired
- 1985-09-06 AT AT85401732T patent/ATE40554T1/de not_active IP Right Cessation
- 1985-09-06 DE DE8585401732T patent/DE3568045D1/de not_active Expired
- 1985-09-26 ES ES547315A patent/ES8605522A1/es not_active Expired
- 1985-09-26 HU HU853694A patent/HU192365B/hu not_active IP Right Cessation
- 1985-09-26 GR GR852356A patent/GR852356B/el unknown
- 1985-09-26 JP JP60214460A patent/JPS61106577A/ja active Pending
- 1985-09-26 FI FI853719A patent/FI82054C/fi not_active IP Right Cessation
- 1985-09-26 NO NO853782A patent/NO162821C/no unknown
- 1985-09-26 NZ NZ213620A patent/NZ213620A/en unknown
- 1985-09-26 ZA ZA857457A patent/ZA857457B/xx unknown
- 1985-09-26 CA CA000491635A patent/CA1291994C/en not_active Expired - Fee Related
- 1985-09-26 DK DK435285A patent/DK158953C/da not_active IP Right Cessation
- 1985-09-26 KR KR1019850007089A patent/KR860002508A/ko not_active Application Discontinuation
- 1985-09-26 PT PT81206A patent/PT81206B/pt not_active IP Right Cessation
- 1985-09-26 US US06/780,453 patent/US4661498A/en not_active Expired - Fee Related
- 1985-09-27 AU AU47952/85A patent/AU573390B2/en not_active Ceased
- 1985-09-29 IL IL76535A patent/IL76535A0/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2570701A1 (fr) | 1986-03-28 |
| ES8605522A1 (es) | 1986-03-16 |
| ES547315A0 (es) | 1986-03-16 |
| FI853719L (fi) | 1986-03-28 |
| FI82054C (fi) | 1991-01-10 |
| IL76535A0 (en) | 1986-02-28 |
| ZA857457B (en) | 1986-05-28 |
| HU192365B (en) | 1987-05-28 |
| AU573390B2 (en) | 1988-06-09 |
| JPS61106577A (ja) | 1986-05-24 |
| DK435285D0 (da) | 1985-09-26 |
| EP0178201B1 (fr) | 1989-02-01 |
| PT81206B (pt) | 1988-01-22 |
| FI853719A0 (fi) | 1985-09-26 |
| NZ213620A (en) | 1988-01-08 |
| NO853782L (no) | 1986-04-01 |
| EP0178201A1 (fr) | 1986-04-16 |
| US4661498A (en) | 1987-04-28 |
| NO162821B (no) | 1989-11-13 |
| GR852356B (da) | 1986-01-28 |
| DK158953C (da) | 1991-01-14 |
| FI82054B (fi) | 1990-09-28 |
| DE3568045D1 (en) | 1989-03-09 |
| ATE40554T1 (de) | 1989-02-15 |
| DK158953B (da) | 1990-08-06 |
| CA1291994C (en) | 1991-11-12 |
| PT81206A (fr) | 1985-10-01 |
| DK435285A (da) | 1986-03-28 |
| AU4795285A (en) | 1986-04-10 |
| HUT38945A (en) | 1986-07-28 |
| KR860002508A (ko) | 1986-04-26 |
| FR2570701B1 (fr) | 1987-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO883994L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer. | |
| DK53285D0 (da) | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme | |
| NO162821C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive furo-pyridinderivater. | |
| DK527984D0 (da) | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika | |
| DK408083A (da) | Isoquinolinderivater, deres fremstilling og anvendelse | |
| DE3564684D1 (en) | Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application | |
| PH25106A (en) | 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof | |
| NO167286C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater. | |
| NO883262D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
| DK148288A (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
| NO169442C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser | |
| ATE47135T1 (de) | Antikonvulsive mittel. | |
| NO164901C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetraoxo-3,7-diazabicyclo (3,3,1)-nonanforbindelser. | |
| DK364386A (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| ES2004255A6 (es) | Procedimiento de preparar compuestos del tipo de las piracinas y analogos. | |
| DK74594A (da) | Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf |